← Back to headlines
Mirum Pharmaceuticals Reports Positive Phase 2b Data for Volixibat
Mirum Pharmaceuticals (MIRM) announced positive Phase 2b data for its drug Volixibat in patients with Primary Sclerosing Cholangitis (PSC) at the EASL Congress.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
3h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
10h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
13h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
21h ago